CCR3 deficiency is associated with increased osteoclast activity and reduced cortical bone volume in adult male mice.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
Historique:
received: 16 10 2020
revised: 25 11 2020
accepted: 10 12 2020
pubmed: 12 12 2020
medline: 19 8 2021
entrez: 11 12 2020
Statut: ppublish

Résumé

Increasing evidence emphasizes the importance of chemokines and chemokine receptors as regulators of bone remodeling. The C-C chemokine receptor 3 (CCR3) is dramatically upregulated during osteoclastogenesis, but the role of CCR3 in osteoclast formation and bone remodeling in adult mice is unknown. Herein, we used bone marrow macrophages derived from adult male CCR3-proficient and CCR3-deficient mice to study the role of CCR3 in osteoclast formation and activity. CCR3 deficiency was associated with formation of giant hypernucleated osteoclasts, enhanced bone resorption when cultured on bone slices, and altered mRNA expression of related chemokine receptors and ligands. In addition, primary mouse calvarial osteoblasts isolated from CCR3-deficient mice showed increased mRNA expression of the osteoclast activator-related gene, receptor activator of nuclear factor kappa-B ligand, and osteoblast differentiation-associated genes. Microcomputed tomography analyses of femurs from CCR3-deficient mice revealed a bone phenotype that entailed less cortical thickness and volume. Consistent with our in vitro studies, the total number of osteoclasts did not differ between the genotypes in vivo. Moreover, an increased endocortical osteoid mineralization rate and higher trabecular and cortical bone formation rate was displayed in CCR3-deficient mice. Collectively, our data show that CCR3 deficiency influences osteoblast and osteoclast differentiation and that it is associated with thinner cortical bone in adult male mice.

Identifiants

pubmed: 33303631
pii: S0021-9258(20)00173-8
doi: 10.1074/jbc.RA120.015571
pmc: PMC7948475
pii:
doi:

Substances chimiques

Ccr3 protein, mouse 0
NF-kappa B 0
RANK Ligand 0
Receptors, CCR3 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100177

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.

Références

Sci Rep. 2017 Jul 13;7(1):5334
pubmed: 28706221
Proc Natl Acad Sci U S A. 1990 Jun;87(12):4473-5
pubmed: 1693772
J Biol Chem. 1996 Mar 29;271(13):7725-30
pubmed: 8631813
Cell Biol Toxicol. 2017 Feb;33(1):15-26
pubmed: 27495116
Nat Immunol. 2001 Feb;2(2):95-101
pubmed: 11175800
Nat Med. 2009 Apr;15(4):417-24
pubmed: 19330010
Biosci Rep. 2006 Oct;26(5):325-39
pubmed: 17024562
J Cell Biochem. 2016 Feb;117(2):382-9
pubmed: 26205994
J Cell Biochem. 2019 Aug;120(8):13974-13984
pubmed: 30977156
J Bone Miner Res. 2013 Oct;28(10):2070-80
pubmed: 23553711
PLoS One. 2015 Aug 04;10(8):e0134608
pubmed: 26241961
J Cell Biochem. 2004 Nov 15;93(5):929-39
pubmed: 15389872
J Cell Physiol. 2012 Apr;227(4):1619-27
pubmed: 21678414
Cell Biochem Funct. 2017 Apr;35(3):171-177
pubmed: 28370169
J Bone Miner Res. 2000 Aug;15(8):1477-88
pubmed: 10934646
PLoS Genet. 2020 May 28;16(5):e1008586
pubmed: 32463816
Front Immunol. 2019 Sep 13;10:2182
pubmed: 31572390
Endocrinology. 2005 May;146(5):2324-35
pubmed: 15718270
J Cell Biochem. 2014 Jul;115(7):1290-8
pubmed: 24500983
J Med Biochem. 2019 May 11;38(3):353-360
pubmed: 31156346
J Biol Chem. 2000 Sep 1;275(35):27250-7
pubmed: 10859315
J Biol Chem. 2005 Aug 12;280(32):29011-6
pubmed: 15965235
Immunol Invest. 2013;42(7):555-622
pubmed: 24004059
Immunity. 2012 May 25;36(5):705-16
pubmed: 22633458
Gene. 2020 Sep 5;754:144855
pubmed: 32522695
Arthritis Rheum. 2010 Feb;62(2):383-91
pubmed: 20112361
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Nat Commun. 2017 Dec 20;8(1):2226
pubmed: 29263385

Auteurs

Sara Rosendahl (S)

Department of Odontology, Section of Molecular Periodontology, Umeå University, Umeå, Sweden.

Rima Sulniute (R)

Department of Odontology, Section of Molecular Periodontology, Umeå University, Umeå, Sweden.

Michaela Eklund (M)

Department of Odontology, Section of Molecular Periodontology, Umeå University, Umeå, Sweden.

Cecilia Koskinen Holm (C)

Department of Odontology, Section of Molecular Periodontology, Umeå University, Umeå, Sweden; Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden.

Marcus J O Johansson (MJO)

Department of Odontology, Section of Molecular Periodontology, Umeå University, Umeå, Sweden.

Elin Kindstedt (E)

Department of Odontology, Section of Molecular Periodontology, Umeå University, Umeå, Sweden; Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden. Electronic address: elin.kindstedt@umu.se.

Susanne Lindquist (S)

Department of Odontology, Section of Molecular Periodontology, Umeå University, Umeå, Sweden.

Pernilla Lundberg (P)

Department of Odontology, Section of Molecular Periodontology, Umeå University, Umeå, Sweden. Electronic address: pernilla.lundberg@umu.se.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH